PATENT CLAIM ANALYSIS

Application Number: 16168002
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["435", "194000"]

Abstract:
The present disclosure provides methods and systems for amplifying and analyzing nucleic acid samples. The present disclosure provides methods for preparing cDNA and/or DNA molecules and cDNA and/or DNA libraries using modified reverse transcriptases.

Claim (Index 9):
The method of  claim 1 , wherein said R2 reverse transcription enzyme is configured to generate said plurality of complementary deoxyribonucleic acid molecules from said one or more template ribonucleic acid molecules with a specific activity of from about 20,000 units/mg to about 140,000 units/mg.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 97.0
- Lexical Diversity: 1.5
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15410211', '12095409', '14414104', '10362703', '10178673']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.649048008241529
- 35 USC 102 Novelty (BERT): 0.5133785517038486
- Combined Prediction Score: 0.6354810625877609
- Mean Citation Score: 289.7231060000001
- Max Citation Score: 300.6831
- Similarity Product: 209.2772417112172

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test